No family should suffer from cervical cancer twice – the palliative care role in HPV prevention; Iyengar S, Kantor K, Cyriac S, Remadevi K, Usha V, Robinson S, Rani A, Rajagopal MR, Broderick A.J Pain Symptom Manage. 2021 Jul 10;S0885-3924(21)00420-6
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in Myelofibrosis;Sunu Cyriac, Shruti Prem, AuroViswabandya et al; Eur J Haematol. 2021 Jul 14. doi:10.1111/ejh.13689. Online ahead of print
Research Biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions and preferences; AinhoaMadariaga, Sunu Cyriac,Amit M. Oza, Stephanie Lheureux,doi.org/10.1016/j.ajog.2021.06.071; Available online 23 June 2021
HPV vaccine: Expanding indications and global disparity. Christina Uwins, Sunu Cyriac, GeetuBhandoria; Vaccine2021 Jun 29;39(29):3787-3789
Retrospective Analysis of Early Impact of COVID-19 on Systemic Cancer Treatment—A Pilot Study; Sunu L Cyriac, AnakhaPattiyeil, Febin Antony. Indian Journal of Medical and Paediatric Oncology 2021; 42(01): 015-020; DOI: 10.1055/s-0041-1730239
Updates on systemic therapy for cervical cancer (invited review-accepted for publication in Gynecology and breast cancer special edition, Jan 2021). Cyriac S,Gopu P, Antony F, Oza A M, KarakasisK; Ind J Med ResJan 2021
Knowledge, Attitude and Practice of Indian Oncology Residents on Clinical Trials: An Observational StudyRanjith Kumar CS*, SmitaKayal, Biswajit Dubashi,Cyriac S et al. J cancer Clin Trials;Volume 5:3, 2020
Delivery of Cancer Care in India and Canada: Opportunities for Bidirectional Learning, Cyriac S, Booth CM. J Glob Oncol. 2019 Oct;5:1-5
Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions.Pillai US, Kayal S, Cyriac S, Nisha Y, Dharanipragada K, Kamalanathan SK, Halanaik D, Kumar N, Madasamy P, Muniswamy DK, Dubashi B. Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2673-2679
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J, Allard JP, Stuart-McEwan T, Nathwani K, Bowering V, Karakasis K, O'Brien C, Shlomovitz E, Ferguson SE, Buchanan S, Ng P, Cyriac S, Tinker L, Dhani N, Oza AM, Lheureux S. J Oncol Pract. 2019 Dec;15(12):e1066-e1075
POEMS Syndrome: Indian Experience From a Tertiary-Care Institute; Pramanik A, S Cyriac, L Kumar et al, Clin Lymphoma Myeloma Leuk. 2019 May 29. pii: S2152-2650(19)30062-X
S Panda, S Cyriac, B Dubashi et al, Adolescent and Young Adults with Gastric Cancer (AYA-GC)—The Dilemma of an Under-Represented Group: A Multi-Institutional Analysis from the Indian Subcontinent; South Asian J Can 2023; 01:1-92|e1; DOI 10.1055/s-0043-177127
S Cyriac, A Garcia-Horton, , J Mattsson, FV Michelis et al; Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups; Eur J Haematol, 2022 Aug 26 DOI: 10.1111/ejh.13850
Sunu Cyriac, Varun Narayan; Marked New Bone Formation on Treatment of Multiple Myeloma; Mayo Clin Proc, 2022; doi: 10.1016/j.mayocp. 2022.03.002
Al-Shaibani E, Cyriac S, Michelis Fotios V, et al; Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia; Clin Lymphoma Myeloma Leuk. 2021 Jun. doi: 10.1016/j.clml.2021.01.022
Cyriac S, Katherine Karakasis, Amit M. Oza; Rucaparib for the treatment of ovarian cancer; Expert Opinion on Orphan Drugs Vol 6, 2018 - Issue 2
Cyriac S, Amit M. Oza, K Karakasis; DNA Repair Defects for Therapy in Ovarian Cancer: The BRCA1/ 2 and PARP Inhibitor Story; Ind J Gynec Oncol 2017 Doi
10.1007/s40944-017-0155-8
Rajagopal MD, Kar R, Basu D, Cyriac SL et al; Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls; Ind J Pathol Micro. 2017;doi: 10.4103/IJPM.IJPM_139_16
Pillai, U, Cyriac, S, Badhe, B. et al; Impact of Oncologist Initiated Selective Review of Pathology Specimens in Multidisciplinary Onco-pathological Discussions on the Management of Malignancies in a University Hospital in India; J of Adv in Med and Medical Res 2016 https://doi. org /10. 9734/BJMMR/2016/27156
Ramakrishnaiah VP , Kotlapati S, Cyriac S et al; Palliation of Dysphagia in Carcinoma Esophagus, Clin Med Insights Gastroenterol 2016; doi: 10.4137/CGast.S30303
Jain D, Cyriac S, Mathur SR, Kumar L, Guleria R et al; Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study; Ind J Med Res. 2016. doi: 10.4103/0971-5916.182621
Dhanraj KM, Kayal S, Cyriac S. et al; Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and Docetaxel 75 versus AC and Docetaxel in locally advanced breast cancer: a randomized clinical study; Med Oncol 2015 Dec; doi: 10.1007/s12032-015-0697-5
Cyriac S, Walia R, Suri V, Bakhshi S; Colonic Malignant Peripheral Nerve Sheath Tumor in a Child; J Ped Hemat/Oncol: Nov 2014; doi: 10.1097/ MPH.0b013e318290bc9f
Kayal S, Sharma A, Tejomurtula T, Cyriac S, Raina V. et al; High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: A Single Institution Experience at All India Institute of Medical Sciences, New Delhi, Using Non-Cryopreserved Peripheral Blood Stem Cells. Clin Lymp Myel Leuk. 2014. Doi:10.1016/j.clml.2013.09.001
Kumar L, Cyriac S, Sharma O, et al; Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors; Clin Lymp Myel Leuk 2013; doi:10.1016/j.clml.2012.08.007
Gauri Kapoor, Sunu Lazar Cyriac, V P Gangadharan, Prashant Mathur et al; Profile of Childhood Cancers From Hospital-Based Cancer Registries in India, 2012-19; Indian Pediatr. 2024 Jan 15;61(1):39-44.
